UCT researchers shine at SAMRC Scientific Merit Awards

24 Oct 2016 - 10:45

Gold Medal – Kelly Chibale

Professor Kelly Chibale from the Department of Chemistry was awarded a Gold Medal, which is conferred on researchers for major scientific breakthroughs.

Professor Chibale is a full professor of organic chemistry. He is a full member of the UCT Institute of Infectious Disease and Molecular Medicine (IDM), a Tier 1 Department of Science and Technology/National Research Foundation South Africa Research Chair Initiative in Drug Discovery, founding director of the Medical Research Council (MRC) Drug Discovery and Development Research Unit at UCT and the founder and director of the UCT Drug Discovery and Development Centre (H3D).

Kelly obtained his PhD in synthetic organic chemistry from the University of Cambridge in the UK (1989-1992). This was followed by postdoctoral stints at the University of Liverpool in the UK (1992-94) and at the Scripps Research Institute in the USA (1994-96). He was a Sandler sabbatical fellow at the University of California San Francisco (2002), a US Fulbright senior research scholar at the University of Pennsylvania School Of Medicine (2008) and a visiting professor at Pfizer in the UK (2008).

Compiled by Birgit Ottermann. Images by Michael Hammond.

Kelly Chibale: chemistry his calling in life

Kelly Chibale didn’t have the easiest start to his academic career. After attending three different primary schools, he had to retake his final examinations in order to attend secondary school in Kasama, the capital of the Northern Province of Zambia. At the end of school, he was unsuccessful in his application to study accounting at university and was forced to take a step back and reconsider his options. In this time, Chibale remembered his fascination with chemical reactions and colour changes at school and decided to study chemistry instead.


Kelly Chibale

During his undergraduate studies at the University of Zambia (UNZA), Chibale’s interest in chemistry continued to grow. He enjoyed the logic of organic chemistry and the way that synthetic chemistry can be used to create new molecules. This passion led Chibale to complete a PhD in synthetic organic chemistry at the University of Cambridge, England.

He followed this with postdoctoral research at the University of Liverpool, England, and the Scripps Research Institute, USA. He then moved to South Africa to take up an appointment as a lecturer at the University of Cape Town (UCT) where he rose through the ranks to become a professor of organic chemistry.

Despite being successful in these endeavours, Chibale admits that he faced challenges along the way: "At UNZA, we had limited infrastructure and resources so we didn’t get much exposure to practical chemistry techniques and equipment. As a result, I didn’t feel adequately prepared for my postgraduate research studies."

Africa needs science, not aid

Throughout his career, Kelly has been inspired by the use of science to support development. In 2010, he founded H3D – a centre for drug discovery which aims to bridge the gap between basic and clinical studies. He explains, "H3D is the first of its kind in Africa. It trains a new generation of African scientists with key skills and competencies in the relevant areas of drug discovery." 

In addition to this, Chibale is the founding director of the South African Medical Research Council Drug Discovery and Development Research Unit at UCT. The unit specialises in the use of innovative drug discovery tools to develop potential medicines for the treatment of endemic African diseases.

Chibale also holds the position of South Africa Research Chair in Drug Discovery. In this, he plays a key part in building capacity by encouraging the integration of various disciplines in the development of new medicines. Although he recognises that Africa’s efforts in this area have, in the past, been "hampered by lack of expertise and infrastructure", Chibale wants to highlight the impact that Africa can have:

“I want to debunk the myth and challenge stereotypical views that Africa cannot be a source of health innovation. There is capacity, albeit limited, in Africa to innovate and for Africans to lead innovation and use the power of scientific research to discover new medicines for the benefit of humanity. Africa is not just a continent where others can come and do clinical trials.”

The power of collaboration

Chibale has a keen interest in multi-disciplinary research and sees collaboration as crucial for addressing scientific challenges. As an example of this, he draws upon a malaria drug discovery project that involves researchers in the fields of medicinal chemistry, biology and pharmacology. The project was led by H3D on African soil but the team worked in collaboration with institutions in Switzerland (Medicines for Malaria Venture and Swiss Tropical and Public Health Institute), India (Syngene) and Australia (Monash University).

“We are all created to depend on each other for common good and there is so much we can learn from each other. Multi-disciplinary research offers the best opportunity to expose students and future scientists to the best possible frontiers in science.”

Promoting diversity

Chibale believes that more can be done to promote diversity in science and technology by providing opportunities to minority groups and allowing others to be inspired and encouraged by them. He emphasises the need for a deliberate effort to nurture and support talent within minority groups.

Finally, Chibale advises others to make the most of their opportunities and use the challenges they face as a source of motivation.

"There are no formulas for success. Don’t conform and don’t let other people define success for you – you will always have critics."

Story by Florence Greatrix. Images, courtesy of Kelly Chibale. First published by the Royal Society of Chemistry. Repubished with kind permission.